Immuno-oncology Drugs Market Report

Global and Region Immuno-oncology Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：150
  • REPORT CODE：GMM966035
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Immuno-oncology Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Immuno-oncology Drugsmarket, defines the market attractiveness level of Immuno-oncology Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Immuno-oncology Drugs industry, describes the types of Immuno-oncology Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Immuno-oncology Drugs market and the development prospects and opportunities of Immuno-oncology Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Immuno-oncology Drugs market in Chapter 13.

    By Player:

    • Galena Biopharma

    • Pfizer Inc

    • Amgen, Inc

    • Bavarian Nordic

    • Incyte

    • AbbVie, Inc

    • Prometheus Therapeutics & Diagnostics

    • AstraZeneca, Plc

    • ImmunoCellular Therapeutics

    • Merck & Co

    • Hoffmann-La Roche AG

    • EMD Serono, Inc

    • Gilead Sciences Inc

    • Aduro BioTech

    • Novartis International AG

    • Sanofi SA

    • Eli Lilly and Company

    • Celgene Corporation

    • Johnson & Johnson

    • Celldex Therapeutics

    • Bristol-Myers Squibb

    By Type:

    • Immune Checkpoint Inhibitors

    • Monoclonal Antibodies

    • Cytokine-Based Immunotherapy

    • Cancer Vaccines

    • CAR-T Cell Therapy

    By End-User:

    • Hospitals

    • Pharmacies

    • Online Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Immuno-oncology Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Immuno-oncology Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Immuno-oncology Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Immuno-oncology Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Immuno-oncology Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Immuno-oncology Drugs Consumption (2017-2022)

    • 7.2 United States Immuno-oncology Drugs Consumption (2017-2022)

    • 7.3 Europe Immuno-oncology Drugs Consumption (2017-2022)

    • 7.4 China Immuno-oncology Drugs Consumption (2017-2022)

    • 7.5 Japan Immuno-oncology Drugs Consumption (2017-2022)

    • 7.6 India Immuno-oncology Drugs Consumption (2017-2022)

    • 7.7 South Korea Immuno-oncology Drugs Consumption (2017-2022)

    8 Region and Country-wise Immuno-oncology Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Immuno-oncology Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Immuno-oncology Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Immuno-oncology Drugs Consumption Forecast (2022-2028)

    • 8.4 China Immuno-oncology Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Immuno-oncology Drugs Consumption Forecast (2022-2028)

    • 8.6 India Immuno-oncology Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Immuno-oncology Drugs Consumption Forecast (2022-2028)

    9 Global Immuno-oncology Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Immuno-oncology Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Cytokine-Based Immunotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Cancer Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global CAR-T Cell Therapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Immuno-oncology Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Immuno-oncology Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Immuno-oncology Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Cytokine-Based Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global CAR-T Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Immuno-oncology Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Immuno-oncology Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Immuno-oncology Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Immuno-oncology Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Immuno-oncology Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Immuno-oncology Drugs Market Competitive Analysis

    • 14.1 Galena Biopharma

      • 14.1.1 Galena Biopharma Company Details

      • 14.1.2 Galena Biopharma Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Galena Biopharma Immuno-oncology Drugs Product and Service

    • 14.2 Pfizer Inc

      • 14.2.1 Pfizer Inc Company Details

      • 14.2.2 Pfizer Inc Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Pfizer Inc Immuno-oncology Drugs Product and Service

    • 14.3 Amgen, Inc

      • 14.3.1 Amgen, Inc Company Details

      • 14.3.2 Amgen, Inc Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Amgen, Inc Immuno-oncology Drugs Product and Service

    • 14.4 Bavarian Nordic

      • 14.4.1 Bavarian Nordic Company Details

      • 14.4.2 Bavarian Nordic Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bavarian Nordic Immuno-oncology Drugs Product and Service

    • 14.5 Incyte

      • 14.5.1 Incyte Company Details

      • 14.5.2 Incyte Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Incyte Immuno-oncology Drugs Product and Service

    • 14.6 AbbVie, Inc

      • 14.6.1 AbbVie, Inc Company Details

      • 14.6.2 AbbVie, Inc Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AbbVie, Inc Immuno-oncology Drugs Product and Service

    • 14.7 Prometheus Therapeutics & Diagnostics

      • 14.7.1 Prometheus Therapeutics & Diagnostics Company Details

      • 14.7.2 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product and Service

    • 14.8 AstraZeneca, Plc

      • 14.8.1 AstraZeneca, Plc Company Details

      • 14.8.2 AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 AstraZeneca, Plc Immuno-oncology Drugs Product and Service

    • 14.9 ImmunoCellular Therapeutics

      • 14.9.1 ImmunoCellular Therapeutics Company Details

      • 14.9.2 ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 ImmunoCellular Therapeutics Immuno-oncology Drugs Product and Service

    • 14.10 Merck & Co

      • 14.10.1 Merck & Co Company Details

      • 14.10.2 Merck & Co Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Merck & Co Immuno-oncology Drugs Product and Service

    • 14.11 Hoffmann-La Roche AG

      • 14.11.1 Hoffmann-La Roche AG Company Details

      • 14.11.2 Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Hoffmann-La Roche AG Immuno-oncology Drugs Product and Service

    • 14.12 EMD Serono, Inc

      • 14.12.1 EMD Serono, Inc Company Details

      • 14.12.2 EMD Serono, Inc Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 EMD Serono, Inc Immuno-oncology Drugs Product and Service

    • 14.13 Gilead Sciences Inc

      • 14.13.1 Gilead Sciences Inc Company Details

      • 14.13.2 Gilead Sciences Inc Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Gilead Sciences Inc Immuno-oncology Drugs Product and Service

    • 14.14 Aduro BioTech

      • 14.14.1 Aduro BioTech Company Details

      • 14.14.2 Aduro BioTech Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Aduro BioTech Immuno-oncology Drugs Product and Service

    • 14.15 Novartis International AG

      • 14.15.1 Novartis International AG Company Details

      • 14.15.2 Novartis International AG Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Novartis International AG Immuno-oncology Drugs Product and Service

    • 14.16 Sanofi SA

      • 14.16.1 Sanofi SA Company Details

      • 14.16.2 Sanofi SA Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Sanofi SA Immuno-oncology Drugs Product and Service

    • 14.17 Eli Lilly and Company

      • 14.17.1 Eli Lilly and Company Company Details

      • 14.17.2 Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Eli Lilly and Company Immuno-oncology Drugs Product and Service

    • 14.18 Celgene Corporation

      • 14.18.1 Celgene Corporation Company Details

      • 14.18.2 Celgene Corporation Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Celgene Corporation Immuno-oncology Drugs Product and Service

    • 14.19 Johnson & Johnson

      • 14.19.1 Johnson & Johnson Company Details

      • 14.19.2 Johnson & Johnson Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Johnson & Johnson Immuno-oncology Drugs Product and Service

    • 14.20 Celldex Therapeutics

      • 14.20.1 Celldex Therapeutics Company Details

      • 14.20.2 Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Celldex Therapeutics Immuno-oncology Drugs Product and Service

    • 14.21 Bristol-Myers Squibb

      • 14.21.1 Bristol-Myers Squibb Company Details

      • 14.21.2 Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Bristol-Myers Squibb Immuno-oncology Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Immuno-oncology Drugs

    • Figure Immuno-oncology Drugs Picture

    • Table Global Immuno-oncology Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Immuno-oncology Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Immuno-oncology Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Immuno-oncology Drugs Consumption by Country (2017-2022)

    • Figure United States Immuno-oncology Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Immuno-oncology Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Immuno-oncology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Immuno-oncology Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Immuno-oncology Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Immuno-oncology Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Immuno-oncology Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Immuno-oncology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Immuno-oncology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Immuno-oncology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Immuno-oncology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Immuno-oncology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Immuno-oncology Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immune Checkpoint Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Cytokine-Based Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global CAR-T Cell Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Immune Checkpoint Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cytokine-Based Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CAR-T Cell Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Immuno-oncology Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Immuno-oncology Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Galena Biopharma (Foundation Year, Company Profile and etc.)

    • Table Galena Biopharma Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Galena Biopharma Immuno-oncology Drugs Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Immuno-oncology Drugs Product and Service

    • Table Amgen, Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen, Inc Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen, Inc Immuno-oncology Drugs Product and Service

    • Table Bavarian Nordic (Foundation Year, Company Profile and etc.)

    • Table Bavarian Nordic Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bavarian Nordic Immuno-oncology Drugs Product and Service

    • Table Incyte (Foundation Year, Company Profile and etc.)

    • Table Incyte Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Incyte Immuno-oncology Drugs Product and Service

    • Table AbbVie, Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie, Inc Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie, Inc Immuno-oncology Drugs Product and Service

    • Table Prometheus Therapeutics & Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Product and Service

    • Table AstraZeneca, Plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca, Plc Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca, Plc Immuno-oncology Drugs Product and Service

    • Table ImmunoCellular Therapeutics (Foundation Year, Company Profile and etc.)

    • Table ImmunoCellular Therapeutics Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table ImmunoCellular Therapeutics Immuno-oncology Drugs Product and Service

    • Table Merck & Co (Foundation Year, Company Profile and etc.)

    • Table Merck & Co Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Immuno-oncology Drugs Product and Service

    • Table Hoffmann-La Roche AG (Foundation Year, Company Profile and etc.)

    • Table Hoffmann-La Roche AG Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hoffmann-La Roche AG Immuno-oncology Drugs Product and Service

    • Table EMD Serono, Inc (Foundation Year, Company Profile and etc.)

    • Table EMD Serono, Inc Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table EMD Serono, Inc Immuno-oncology Drugs Product and Service

    • Table Gilead Sciences Inc (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Inc Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Inc Immuno-oncology Drugs Product and Service

    • Table Aduro BioTech (Foundation Year, Company Profile and etc.)

    • Table Aduro BioTech Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aduro BioTech Immuno-oncology Drugs Product and Service

    • Table Novartis International AG (Foundation Year, Company Profile and etc.)

    • Table Novartis International AG Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International AG Immuno-oncology Drugs Product and Service

    • Table Sanofi SA (Foundation Year, Company Profile and etc.)

    • Table Sanofi SA Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA Immuno-oncology Drugs Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Immuno-oncology Drugs Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Immuno-oncology Drugs Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Immuno-oncology Drugs Product and Service

    • Table Celldex Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Celldex Therapeutics Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celldex Therapeutics Immuno-oncology Drugs Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Immuno-oncology Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Immuno-oncology Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US